Industry associations play a strong role in helping the pharmaceutical industry meet challenges.
When using media supplements in biologics, it is important to have a key understanding of both the supplement and the base medium to ensure high titer and stability.
The authors describe the development and validation of a highly sensitive point-of-use pressure decay test.
The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
AAPS supports graduate-level programs impacted by cutbacks in funding and resources.
Cellular therapy developers learn process development strategies from pharma industry experiences.
Despite different material, agitation, and aeration, the performance of the disposable bioreactor is similar to that of stainless steel bioreactors.
The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.
Increased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
This application note presents a protocol for Sf9 insect cell culture in stirred-tank bioreactors and recombinant protein production via a baculovirus vector system.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
The authors discuss complications of implementing continued process verification and provide recommended approaches.
A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.
A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.
The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
Program review can help quality risk management live up to the promise of ICH Q9.
The authors discuss complications of implementing continued process verification and provide recommended approaches.
AAPS supports graduate-level programs impacted by cutbacks in funding and resources.
Selecting a delivery method early on may be beneficial.